Placenta-specific plasma miR518b is a potential biomarker for preeclampsia.

Abstract:
INTRODUCTION:MicroRNAs have a significant role in the pathogenesis of preeclampsia. Circulating microRNAs could represent a potential biomarker for preeclampsia. The aim of this study was to evaluate plasma miR210-3p and miR518b in preeclampsia and healthy pregnancy for the first time by digital droplet PCR (ddPCR). METHODS:Thirty-six pregnant women (seventeen healthy pregnancies, nineteen preeclampsia patients) were involved from the Clinic for Gynaecology and Obstetrics "Narodni front" in Belgrade, Serbia. Plasma miR210-3p, miR518b and cel-miR-39 as a spike-in control were measured by ddPCR. RESULTS:MiR518b was significantly elevated in preeclampsia compared to a healthy pregnancy (P=0.034; 0.302(0.217-0.421) vs. 0.171(0.110-0.266)). MiR210-3p showed no significant difference between the two groups (P=0.951). The adjustment of miR518b was made for a gestational age and smoking status and the difference between the preeclampsia and healthy pregnancy group was more significant (P=0.026; 0.300(0.216-0.419) vs. 0.172(0.121-0.245)). Plasma miR-518b was significantly higher in the group of preeclampsia patients with proteinuria above the 75th percentile for the group (P=0.033), in women who smoked (P=0.039), and was positively related to uric acid in preeclampsia (P=0.018, r=0.536). Plasma miR518b was able to significantly discriminate between preeclampsia and healthy pregnancy, yielding AUC of 0.712 (95%CI:0.539-0.891), P=0.028. CONCLUSIONS:In this study plasma microRNA were measured for the first time in preeclampsia and healthy pregnancies with ddPCR. Placenta-specific miR-518b could serve as a potential biomarker for discriminating preeclampsia and healthy pregnancy, which should be confirmed on a larger study population. This study has failed to confirm the same potential for miR210-3p.
展开更多
CLINICAL BIOCHEMISTRY
CLIN BIOCHEM
最新影响因子:3.625 | 期刊ISSN:0009-9120 | CiteScore:2.35 |
出版周期:Bimonthly | 是否OA:YES | 出版年份:1967 |
期刊官方网址:http://www.journals.elsevier.com/clinical-biochemistry/
自引率:6.30% | 研究方向:医学-医学实验技术 |
出版地区:CANADA |
SCI期刊coverage:Science Citation Index Expanded(科学引文索引扩展)
官方内部论文预审系统 :
1-3天杂志社编辑直接预审
预审通过后100%录用,3个月即可录用

微信扫码咨询
CLINICAL BIOCHEMISTRY 期刊简介
英文简介:
Clinical Biochemistry publishes articles relating to the applications of molecular biology, biochemistry, chemistry and immunology to clinical investigation and to the diagnosis, therapy, and monitoring of human disease. Manuscripts are categorized as Analytical or Clinical Investigations and may be offered as Full Papers or as Capsules. Critical Reviews are welcome, but contributors are encouraged to contact the Editor-in-Chief to avoid conflict with other forthcoming Reviews.
中文简介:(来自Google、百度翻译)
临床生物化学发表有关分子生物学、生物化学、化学和免疫学在临床研究、诊断、治疗和监测人类疾病中的应用的文章。手稿被分类为分析或临床调查,并可提供完整的论文或胶囊。我们欢迎批评性的评论,但也鼓励投稿者联系总编,避免与其他即将发表的评论发生冲突。
CLINICAL BIOCHEMISTRY 期刊中科院评价数据
最新中科院分区
大类(学科) | 小类(学科) | 学科排名 |
医学 |
MEDICAL LABORATORY TECHNOLOGY(医学实验室技术) 3区 |
13/30 |
最新公布的期刊年发文量
年度总发文量 | 年度论文发表量 | 年度综述发表量 |
213 | 190 | 23 |
影响因子趋势图
CLINICAL BIOCHEMISTRY 期刊CiteScore评价数据
最新CiteScore值
引文计数(2018)
文献(2015-2017)
1991次引用
846篇文献
CiteScore排名
序号 | 类别 | 排名 | 百分位 |
1 |
大类(学科):Biochemistry, Genetics and Molecular Biology
小类(学科):Clinical Biochemistry
|
#52/118
点击查看排名表
|
|
CiteScore趋势图
Scopus涵盖范围
CLINICAL BIOCHEMISTRY 期刊常见问题
热门常见问题
权益保障
-
刊物信息可查
推荐刊物均可到国家新闻出
版总署网站查询正刊 -
严格保密协协议
可签署保密协议 ,不透露任
何用户信息可跟踪进程,全程
协议 -
售后服务保障
1对1服务,7x24小时在线
-
企业信誉保障
12年经验沉淀,实体公司
运营
最新评论(不代表本站观点)
-
liting7111
杂志还算不错,审稿速度块,投稿后一周就送外审,外审两周,三周就有消息了。8月8号投稿,9月13号接受,虽然分不高,不过还是很高兴,感激!2020-06-25 -
liting7111
整体速度还行,提交到接受一共用了两个半月,感觉投稿难度适中,比较容易中!2020-06-22 -
liting7111
研究方向:生命科学 微生物学 病毒学
审稿时间: 2个月内
10月底投稿,12月11号修回,给了两个月时间,拖到最后两天才在2月8号修回,3月1号接受了。2020-06-11 -
liting7111
1月底投稿,3月9日给了待续,4月15日修回,第二天晚上接受了。实验是我自己做的,也是第一篇SCI,杂志感觉很友好!2020-06-07 -
liting7111
投稿两个月了,还在process in decision,天哪 这是什么鬼速度2020-05-26 -
liting7111
研究方向:临床检验
审稿时间: 3个月内 接受率: 比较困难(25%命中)
2013年3月7号提交 3月11号带编辑 3月22号正在审查中 5月18号完成所需的审核 5月24号正在进行的决定 5月26号拒绝!临床检验方向,审稿有两个人,意见主要是内容不够充实。一审三个月左右,这速度太慢耽误我毕业了。2020-05-24 -
liting7111
审稿一点都不快啊!快两个月了还在with editor!2020-03-22 -
liting7111
小修一次今天正式接收,想问问各位前辈我现在是不是只要等通知就行了,还需要做什么工作吗?2020-02-13 -
liting7111
接受率: 比较困难(25%命中)
之前投过两篇,有一篇被拒,第二篇初审已经过了,修了两次,今天早上收到接收邮件了。 6月14日投稿,7月8日审稿意见,7月19日修回,8月6日第二次审稿意见,8月14日第二次 修回,今天早上收到接收通知。我的第二篇SCI文章,还好结果all right。感谢大家的投稿经验,我还要继续努力。2020-02-08 -
liting7111
两个月从审稿到接受,没要求修改,直接接受,个人感觉还不错~2019-07-17 -
liting7111
审稿非常慢,投稿到接受差不多一年时间,太长了!2019-04-22 -
liting7111
审稿时间: 3个月内
8月底投稿,10月2号小修,11月3号接受了,非常nice的杂志!2019-03-09
相关期刊
-
Medical Law Review...
影响因子:2.032
ISSN:0967-0742
研究方向:MEDICAL ETHICS-
-
JOURNAL OF LAW MEDICINE & ETHICS...
影响因子:1.604
ISSN:1073-1105
研究方向:医学-医学:法
-
MEDICINE SCIENCE AND THE LAW...
影响因子:2.051
ISSN:0025-8024
研究方向:医学-医学:法
-
FOOD AND DRUG LAW JOURNAL...
影响因子:0.442
ISSN:1064-590X
研究方向:医学-食品科技
-
AMERICAN BUSINESS LAW JOURNAL...
影响因子:1.743
ISSN:0002-7766
研究方向:
-
European Business Organization Law Review...
影响因子:1.79
ISSN:1566-7529
研究方向:
-
Journal of World Energy Law & Business...
影响因子:0.403
ISSN:1754-9957
研究方向:
-
International Insolvency Review...
影响因子:0.646
ISSN:1180-0518
研究方向:
-
JOURNAL OF CRIMINAL LAW & CRIMINOLOGY...
影响因子:2.184
ISSN:0091-4169
研究方向:
CLINICAL BIOCHEMISTRY 投稿经验
(由下方点评分析获得,12人参与,4062人阅读)